SCHEMBL1675314

SCHEMBL1675314

CCOC(=O)c1ccoc1-c1ccc2ncnc(NCCc3c[nH]cn3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 12/20 0.44
CLK1 P49759 4/20 0.44
CLK2 P49760 3/20 0.44
DYRK1A Q13627 3/20 0.44
DYRK1B Q9Y463 3/20 0.44
HTT P42858 1/20 0.41
ALDH1A1 P00352 11/20 0.41
CYP1A2 P05177 10/20 0.41
HSD17B10 Q99714 9/20 0.41
USP2 O75604 6/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
CYP3A4 P08684 9/20 0.39
HIF1A Q16665 4/20 0.39
LMNA P02545 4/20 0.39
CYP2D6 P10635 6/20 0.39
CYP2C19 P33261 5/20 0.39
TSHR P16473 3/20 0.39
PDE5A O76074 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675185 0.83 CLK4 (0.65) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675238 0.79 CLK1 (0.58) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675323 0.78 CLK4 (0.53) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675204 0.78 CLK1 (0.71) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675157 0.74 CLK4 (0.62) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675356 0.73 CLK4 (0.49) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675093 0.73 CLK4 (0.61) CLK4CLK1CLK2DYRK1ADYRK1B
SCHEMBL1675360 0.73 CLK4 (0.57) CLK4HTTALDH1A1CYP1A2HSD17B10
SCHEMBL1675348 0.73 DYRK1A (0.43) CLK4DYRK1AALDH1A1CYP1A2HSD17B10
SCHEMBL1675044 0.72 CLK4 (0.51) CLK4DYRK1AALDH1A1CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed